{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:41:02Z","timestamp":1788172862176,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1055865"],"award-info":[{"award-number":["OPP1055865"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["095009"],"award-info":[{"award-number":["095009"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["070114"],"award-info":[{"award-number":["070114"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["080025"],"award-info":[{"award-number":["080025"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["094780"],"award-info":[{"award-number":["094780"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ebiom.2018.07.024","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T09:32:53Z","timestamp":1532511173000},"page":"158-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania"],"prefix":"10.1016","volume":"34","author":[{"given":"Nathaniel","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Makani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furahini","family":"Tluway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Makubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant-Rayn","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal","family":"Drakesmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2018.07.024_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.21952","article-title":"Reconstructing sickle cell disease: A data-based analysis of the \u2018hyperhemolysis paradigm\u2019 for pulmonary hypertension from the perspective of evidence-based medicine","volume":"86","author":"Hebbel","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/tmi.12428","article-title":"Health policy for sickle cell disease in Africa: Experience from Tanzania on interventions to reduce under-five mortality","volume":"20","author":"Makani","year":"2015","journal-title":"Trop Med Int Heal"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/asheducation-2013.1.447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"2013","author":"Porter","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tips.2014.01.004","article-title":"The pathophysiology and pharmacology of hepcidin","volume":"35","author":"Ruchala","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0035","first-page":"443","article-title":"Assessment of iron status","author":"Gibson","year":"2005","journal-title":"Princ Nutr Assess"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0040","first-page":"792","article-title":"Iron stores in adults with sickle cell anemia","volume":"103","author":"Rao","year":"1984","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/bjh.12791","article-title":"Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania","volume":"165","author":"Cox","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0050","doi-asserted-by":"crossref","first-page":"472909","DOI":"10.1155\/2013\/472909","article-title":"Hematological and genetic predictors of daytime hemoglobin saturation in Tanzanian children with and without sickle cell Anemia","volume":"2013","author":"Cox","year":"2013","journal-title":"ISRN Hematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2141.1996.284816.x","article-title":"Determinants of haemoglobin level in steady-state homozygous sickle cell disease","volume":"92","author":"Serjeant","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2141.2010.08215.x","article-title":"Association of G6PD202A,376G with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia","volume":"150","author":"Nouraie","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1043454213514632","article-title":"Fatigue in adolescents and young adults with sickle cell disease: Biological and behavioral correlates and health-related quality of life","volume":"31","author":"Ameringer","year":"2014","journal-title":"J Pediatr Oncol Nurs"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014699","article-title":"Mortality in sickle cell anemia in africa: A prospective cohort study in Tanzania","volume":"6","author":"Makani","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0075","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1002\/ajh.24193","article-title":"Iron restriction in sickle cell anemia: Time for controlled clinical studies","volume":"90","author":"Castro","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.10313","article-title":"Iron in sickle cell disease: A review why less is better","volume":"73","author":"Koduri","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008249","article-title":"Expression of the iron hormone hepcidin distinguishes different types of anemia in african children","volume":"6","author":"Pasricha","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/ATVBAHA.113.302381","article-title":"Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population","volume":"34","author":"Galesloot","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0100","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3324\/haematol.2008.003152","article-title":"Regulation of serum hepcidin levels in sickle cell disease","volume":"94","author":"Kroot","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mpr.329","article-title":"Multiple imputation by chained equations: What is it and how does it work?","volume":"20","author":"Azur","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1467-985X.00122","article-title":"Building multivariable prognostic and diagnostic models: Transformation of the predictors by using fractional polynomials","volume":"162","author":"Sauerbrei","year":"1999","journal-title":"J R Stat Soc Ser A"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0115","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2011-11-391219","article-title":"Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children","volume":"119","author":"Prentice","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0120","series-title":"Immunoassay for human serum erythroferrone","author":"Ganz","year":"2017"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1179\/2046905511Y.0000000009","article-title":"Utility of plasma transferrin receptor, ferritin and inflammatory markers in children with sickle cell disease","volume":"32","author":"Al-Saqladi","year":"2012","journal-title":"Paediatr Int Child Health"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcmd.2015.07.010","article-title":"Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease","volume":"55","author":"Karafin","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood.V67.1.46.46","article-title":"Sickle cell anemia patients have low erythropoeitin levels for thei degree of anemia","volume":"67","author":"Sherwood","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0140","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1182\/blood.V58.5.963.963","article-title":"The diagnosis of iron deficiency anemia in sickle cell disease","volume":"58","author":"Vichinsky","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pbc.22471","article-title":"Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease","volume":"55","author":"Lulla","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1172\/JCI111181","article-title":"Concurrent sickle cell anemia and alpha-thalassemia. Effect of pathological properties of sickle erythrocytes","volume":"73","author":"Embury","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0155","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): A trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0160","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/jcp.2009.066498","article-title":"New cut-off values for ferritin and soluble transferrin receptor for the assessment of iron deficiency in children in a high infection pressure area","volume":"62","author":"Phiri","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0165","series-title":"Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region","first-page":"1011","volume":"15","author":"Buchanan","year":"2012"},{"key":"10.1016\/j.ebiom.2018.07.024_bb0170","first-page":"1","article-title":"Erythropoietin in the general population: Reference ranges and clinical, biochemical and genetic correlates","volume":"10","author":"Beverborg","year":"2015","journal-title":"PLoS One"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418302676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418302676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:50:13Z","timestamp":1762455013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418302676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"alternative-id":["S2352396418302676"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.07.024","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}